Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Alcohol Collaborators

Abstract

Background: Alcohol use is a leading risk factor for death and disability, but its overall association with health remains complex given the possible protective effects of moderate alcohol consumption on some conditions. With our comprehensive approach to health accounting within the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we generated improved estimates of alcohol use and alcohol-attributable deaths and disability-adjusted life-years (DALYs) for 195 locations from 1990 to 2016, for both sexes and for 5-year age groups between the ages of 15 years and 95 years and older.

Methods: Using 694 data sources of individual and population-level alcohol consumption, along with 592 prospective and retrospective studies on the risk of alcohol use, we produced estimates of the prevalence of current drinking, abstention, the distribution of alcohol consumption among current drinkers in standard drinks daily (defined as 10 g of pure ethyl alcohol), and alcohol-attributable deaths and DALYs. We made several methodological improvements compared with previous estimates: first, we adjusted alcohol sales estimates to take into account tourist and unrecorded consumption; second, we did a new meta-analysis of relative risks for 23 health outcomes associated with alcohol use; and third, we developed a new method to quantify the level of alcohol consumption that minimises the overall risk to individual health.

Findings: Globally, alcohol use was the seventh leading risk factor for both deaths and DALYs in 2016, accounting for 2·2% (95% uncertainty interval [UI] 1·5-3·0) of age-standardised female deaths and 6·8% (5·8-8·0) of age-standardised male deaths. Among the population aged 15-49 years, alcohol use was the leading risk factor globally in 2016, with 3·8% (95% UI 3·2-4·3) of female deaths and 12·2% (10·8-13·6) of male deaths attributable to alcohol use. For the population aged 15-49 years, female attributable DALYs were 2·3% (95% UI 2·0-2·6) and male attributable DALYs were 8·9% (7·8-9·9). The three leading causes of attributable deaths in this age group were tuberculosis (1·4% [95% UI 1·0-1·7] of total deaths), road injuries (1·2% [0·7-1·9]), and self-harm (1·1% [0·6-1·5]). For populations aged 50 years and older, cancers accounted for a large proportion of total alcohol-attributable deaths in 2016, constituting 27·1% (95% UI 21·2-33·3) of total alcohol-attributable female deaths and 18·9% (15·3-22·6) of male deaths. The level of alcohol consumption that minimised harm across health outcomes was zero (95% UI 0·0-0·8) standard drinks per week.

Interpretation: Alcohol use is a leading risk factor for global disease burden and causes substantial health loss. We found that the risk of all-cause mortality, and of cancers specifically, rises with increasing levels of consumption, and the level of consumption that minimises health loss is zero. These results suggest that alcohol control policies might need to be revised worldwide, refocusing on efforts to lower overall population-level consumption.

Funding: Bill & Melinda Gates Foundation.

Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Age-standardised prevalence of current drinking for females (A) and males (B) in 2016, in 195 locations Current drinkers are defined as individuals who reported having consumed alcohol within the past 12 months. ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. Isl=Islands. FSM=Federated States of Micronesia. LCA=Saint Lucia. TTO=Trinidad and Tobago. TLS=Timor-Leste.
Figure 2
Figure 2
Average standard drinks (10 g of pure ethanol per serving) consumed per day, age-standardised, for females (A) and males (B) in 2016, in 195 locations ATG=Antigua and Barbuda. VCT=Saint Vincent and the Grenadines. Isl=Islands. FSM=Federated States of Micronesia. LCA=Saint Lucia. TTO=Trinidad and Tobago. TLS=Timor-Leste.
Figure 3
Figure 3
Attributable DALY rate disaggregated by outcome, shown globally and for each region, by age and sex, in 2016 (A) Females. (B) Males. DALY=disability-adjusted life-year. SDI=Socio-demographic Index.
Figure 3
Figure 3
Attributable DALY rate disaggregated by outcome, shown globally and for each region, by age and sex, in 2016 (A) Females. (B) Males. DALY=disability-adjusted life-year. SDI=Socio-demographic Index.
Figure 4
Figure 4
Relative risk curves for selected conditions by number of standard drinks consumed daily (A) Relative risk curves for breast cancer, ischaemic heart disease, diabetes, and tuberculosis for females. (B) Relative risk curves for lip and oral cavity cancer, ischaemic heart disease, diabetes, and tuberculosis for males. Points are relative risk estimates from studies. The vertical and horizontal bars capture the uncertainty in each study, related to the sample size and number of drinks consumed by individuals in the study. The black line represents the estimated relative risk for each condition at each level of consumption. The shaded green areas represent the 95% uncertainty interval associated with the estimated relative risk. The dotted line is a reference line for a relative risk of 1. The relative risk curves for all other health outcomes associated with alcohol use are presented in appendix 2 (pp 57–146).
Figure 5
Figure 5
Weighted relative risk of alcohol for all attributable causes, by standard drinks consumed per day Age-standardised weights determined by the DALY rate in 2016, for both sexes. The dotted line is a reference line for a relative risk of 1. DALY=disability-adjusted life-year.

References

    1. Ezzati M, Hoorn SV, Lopez AD. Comparative quantification of mortality and burden of disease attributable to selected risk factors. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, editors. Global burden of disease and risk factors. World Bank; Washington (DC): 2006.
    1. Rehm J, Room R, Graham K, Monteiro M, Gmel G, Sempos CT. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction. 2003;98:1209–1228.
    1. Rehm J, Room R, Monteiro M. Alcohol as a risk factor for global burden of disease. Eur Addict Res. 2003;9:157–164.
    1. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.
    1. De Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166:2437–2445.
    1. Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med. 2004;140:211.
    1. Holmes MV, Dale CE, Zuccolo L. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164.
    1. Fillmore KM, Kerr WC, Stockwell T, Chikritzhs T, Bostrom A. Moderate alcohol use and reduced mortality risk: systematic error in prospective studies. Addict Res Theory. 2006;14:101–132.
    1. Naimi TS, Brown DW, Brewer RD. Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults. Am J Prev Med. 2005;28:369–373.
    1. Chikritzhs T, Stockwell T, Naimi T, Andreasson S, Dangardt F, Liang W. Has the leaning tower of presumed health benefits from ‘moderate’ alcohol use finally collapsed? Addiction. 2015;110:726–727.
    1. Forouzanfar MH, Alexander L, Anderson HR. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287–2323.
    1. Lim SS, Vos T, Flaxman AD. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–2260.
    1. WHO . World Health Organization; Geneva: 2014. Global status report on alcohol and health 2014.
    1. Knott CS, Coombs N, Stamatakis E, Biddulph JP. All cause mortality and the case for age specific alcohol consumption guidelines: pooled analyses of up to 10 population based cohorts. BMJ. 2015;350:h384.
    1. Fekjaer HO. Alcohol—a universal preventive agent? A critical analysis. Addiction. 2013;108:2051–2057.
    1. Britton A, Bell S. The protective effects of moderate drinking: lies, damned lies, and… selection biases? Addiction. 2017;112:218–219.
    1. Naimi TS, Stockwell T, Zhao J. Selection biases in observational studies affect associations between ‘moderate’ alcohol consumption and mortality. Addiction. 2017;112:207–214.
    1. Rehm J, Kehoe T, Gmel G, Stinson F, Grant B, Gmel G. Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the US example. Popul Health Metr. 2010;8:3.
    1. Nelson DE, Naimi TS, Brewer RD, Roeber J. US state alcohol sales compared to survey data, 1993–2006. Addiction. 2010;105:1589–1596.
    1. Gakidou E, Afshin A, Abajobir AA. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1345–1422.
    1. Stevens GA, Alkema L, Black RE. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet. 2016;388:e19–e23.
    1. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.
    1. NCBI Resource Coordinators Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2013;41:D8–D20.
    1. Degenhardt L, Whiteford HA, Ferrari AJ, Baxter A, Charlson FJ, Hall W. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease study 2010. Lancet. 2013;382:1564–1574.
    1. Institute for Health Metrics and Evaluation Global Burden of Disease Study 2015 (GBD 2015) Socio-Demographic Index (SDI) 1980–2015.
    1. Gmel G, Gutjahr E, Rehm J. How stable is the risk curve between alcohol and all-cause mortality and what factors influence the shape? A precision-weighted hierarchical meta-analysis. Eur J Epidemiol. 2003;18:631–642.
    1. Holman CD, English DR, Milne E, Winter MG. Meta-analysis of alcohol and all-cause mortality: a validation of NHMRC recommendations. Med J Aust. 1996;164:141–145.
    1. Stockwell T, Zhao J, Panwar S, Roemer A, Naimi T, Chikritzhs T. Do ‘moderate’ drinkers have reduced mortality risk? A systematic review and meta-analysis of alcohol consumption and all-cause mortality. J Stud Alcohol Drugs. 2016;77:185–198.
    1. WHO . World Health Organization; Geneva: 2017. Tackling NCDs: ‘best buys’ and other recommended interventions for the prevention and control of noncommunicable diseases.
    1. Karriker-Jaffe KJ, Room R, Giesbrecht N, Greenfield TK. Alcohol's harm to others: opportunities and challenges in a public health framework. J Stud Alcohol Drugs. 2018;79:239–243.
    1. Holst C, Tolstrup JS, Sørensen HJ, Becker U. Alcohol dependence and risk of somatic diseases and mortality: a cohort study in 19 002 men and women attending alcohol treatment. Addiction. 2017;112:1358–1366.
    1. Topiwala A, Ebmeier KP. Effects of drinking on late-life brain and cognition. Evid-Based Ment Health. 2018;21:12–15.
    1. Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J, for the QalyDays Study Group Contribution of alcohol use disorders to the burden of dementia in France 2008–13: a nationwide retrospective cohort study. Lancet Public Health. 2018;3:e124–e132.

Source: PubMed

3
Subskrybuj